Breathtec Biomedical

Last updated: September 26, 2025

CEO - Bill Dawes
CEO - Bill Dawes
Canada | Funding: $1.1M (+)

Website: http:/breathebiomedical.com

Breathtec Biomedical was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.